Digital Mental Integrated Intervention Technology on Language Improvement on Autistic Patients
Assessment of Digital Mental Integrated Intervention Technology on Language Improvement in Children of Autism: One Centre Study
1 other identifier
observational
150
1 country
1
Brief Summary
Primary aim: evaluate the effect of MITA application on language improvement in children with Autism. Secondary aim: evaluate the effect of MITA application on sociability and cognitive awareness in children with Autism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 20, 2024
CompletedFirst Posted
Study publicly available on registry
December 23, 2025
CompletedDecember 23, 2025
December 1, 2025
2.3 years
September 20, 2024
December 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
evaluate the effect of MITA application on language improvement in children with Autism.
evaluation through :Autism Treatment Evaluation Checklist and Mental Synthesis Evaluation Checklist.
baseline , after 3 months and after 6 months .
Interventions
If an application called Mental Imagery Therapy for Autism (MITA) has an effect on language improvement,sociability and cognitive awareness in a sample of children with Autism to seek to provide a tablet-based therapeutic application as a means of reducing the therapy gap and improve quality of care .
Eligibility Criteria
A sample of Children with ASD who were diagnosed by Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria.
You may qualify if:
- Age: 2 year to 8 years.
- Both sexes
- Diagnosed with autism spectrum disorders
You may not qualify if:
- A history of other developmental disorders or neuropsychiatric disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mohamed Abd EL-Adl El-Sawy, Professor of Pediatrics
Professor of Pediatrics ain shams university
- STUDY DIRECTOR
Ola Ali Khalifa, professor
professor of medical genitics ain shams university
- STUDY DIRECTOR
Azza Mohamed Youssef, professor
Professor of developmental and behavioral pediatrics ain shams university
- PRINCIPAL INVESTIGATOR
Asmaa Wafeek Abdelaziz, assistant professor
assistant prfessor of pediatrics ain shams university
- PRINCIPAL INVESTIGATOR
Sarah Farid Mohamed Fahmy, Associate Proffessor
associate Professor of clinical pharmacy ain shams university
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master student in Pediatric Department
Study Record Dates
First Submitted
September 20, 2024
First Posted
December 23, 2025
Study Start
October 1, 2021
Primary Completion
January 1, 2024
Study Completion
May 1, 2024
Last Updated
December 23, 2025
Record last verified: 2025-12